PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
This Quarter Return
-3.76%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$16.4B
AUM Growth
+$16.4B
(-8.1%)
Cap. Flow
-$276M
Cap. Flow
% of AUM
-1.68%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
327
New
21
Increased
103
Reduced
86
Closed
34
Top Buys
| 1 |
Alibaba
BABA
|
$283M |
| 2 |
Advanced Micro Devices
AMD
|
$127M |
| 3 |
CrowdStrike
CRWD
|
$123M |
| 4 |
Snowflake
SNOW
|
$101M |
| 5 |
Flex
FLEX
|
$92.3M |
Top Sells
| 1 |
Datadog
DDOG
|
$144M |
| 2 |
Microsoft
MSFT
|
$124M |
| 3 |
Reddit
RDDT
|
$123M |
| 4 |
Broadcom
AVGO
|
$114M |
| 5 |
Amphenol
APH
|
$113M |
Sector Composition
| 1 | Technology | 39.77% |
| 2 | Financials | 20.29% |
| 3 | Healthcare | 15.67% |
| 4 | Communication Services | 11.2% |
| 5 | Consumer Discretionary | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Commault Systems
CVLT
$8.3B
| $66.9M | 0.41% | 423,843 +60,885 | +17% | +$9.61M |
|
77
Trip.com Group
TCOM
$48.2B
| $66M | 0.4% | 1,037,768 +24,928 | +2% | +$1.58M |
|
78
Arm
ARM
$147B
| $65.3M | 0.4% | 611,759 -152,180 | -20% | -$16.3M |
|
79
Mastercard
MA
$538B
| $62.4M | 0.38% | 113,828 +20,520 | +22% | +$11.2M |
|
80
Nu Holdings
NU
$71.5B
| $62.2M | 0.38% | 6,075,317 +704,907 | +13% | +$7.22M |
|
81
Marvell Technology
MRVL
$54.2B
| $60.7M | 0.37% | 985,171 -715,645 | -42% | -$44.1M |
|
82
Vertex Pharmaceuticals
VRTX
$100B
| $60.6M | 0.37% | 125,000 -50,000 | -29% | -$24.2M |
|
83
Palantir
PLTR
$372B
| $60.1M | 0.37% | 711,647 +473,385 | +199% | +$40M |
|
84
Astera Labs
ALAB
$30.3B
| $59.1M | 0.36% | 990,796 +33,365 | +3% | +$1.99M |
|
85
Insmed
INSM
$28.8B
| $55.6M | 0.34% | 728,755 -1,245 | -0.2% | -$95K |
|
86
JPMorgan Chase
JPM
$829B
| $54.9M | 0.33% | 224,007 -8,355 | -4% | -$2.05M |
|
87
Mirum Pharmaceuticals
MIRM
$3.71B
| $52.9M | 0.32% | 1,175,000 +500,000 | +74% | +$22.5M |
|
88
Brown & Brown
BRO
$32B
| $52.9M | 0.32% | 425,000 +12,500 | +3% | +$1.56M |
|
89
Avidity Biosciences
RNA
$5.99B
| $52.8M | 0.32% | 1,788,868 +516,977 | +41% | +$15.3M |
|
90
First Solar
FSLR
$20.9B
| $52.7M | 0.32% | 417,069 +169,320 | +68% | +$21.4M |
|
91
Samsara
IOT
$20.6B
| $52.3M | 0.32% | 1,365,601 +476,172 | +54% | +$18.3M |
|
92
Aflac
AFL
$57.2B
| $51.1M | 0.31% | 460,000 | – | – |
|
93
IBM
IBM
$227B
| $50.9M | 0.31% | +204,741 | New | +$50.9M |
|
94
Trupanion
TRUP
$1.99B
| $50.3M | 0.31% | 1,350,000 +100,000 | +8% | +$3.73M |
|
95
Madrigal Pharmaceuticals
MDGL
$9.76B
| $49.8M | 0.3% | 150,220 +12,500 | +9% | +$4.14M |
|
96
Zillow
Z
$20.4B
| $49.5M | 0.3% | 722,617 +270,167 | +60% | +$18.5M |
|
|
BPMC
97
DELISTED
Blueprint Medicines
BPMC
| $47.9M | 0.29% | 541,379 -85,000 | -14% | -$7.52M |
|
98
Boston Scientific
BSX
$156B
| $47.5M | 0.29% | 471,113 -3,567 | -0.8% | -$360K |
|
99
Enliven Therapeutics
ELVN
$1.2B
| $46.5M | 0.28% | 2,365,294 -24,374 | -1% | -$480K |
|
100
NewAmsterdam Pharma
NAMS
$2.71B
| $46.1M | 0.28% | 2,250,000 +500,000 | +29% | +$10.2M |
|